1st Slemani Cancer Conference
4 February 2027 · World Cancer DayGrand Millennium Sulaimani, Slemani (Sulaimaniyah), Kurdistan Region – Iraq
Home › Scientific Tracks › Precision Oncology

Precision Oncology

Genomics-guided decisions for every patient
AR
Track Chair
Prof. Alan R. WhitfieldRoyal Marsden Institute, UK
SM
Co-Chair
Dr. Sasan M. AminSulaimani Teaching Hospital, Iraq
About This Track

This track explores how molecular profiling, biomarkers, and targeted therapies are reshaping treatment decisions — and how precision approaches can be implemented in the region.

8+
Sessions
40+
Speakers
100+
Abstracts Expected
Topics Covered
  • Next-generation sequencing in clinical practice
  • Biomarker-driven treatment selection
  • Liquid biopsy and treatment monitoring
  • Molecular tumour boards
  • Access to molecular testing in Iraq & the region
  • Targeted therapy resistance mechanisms
Invited SpeakersView All Speakers →
Abstract Categories
  • Basic and Translational Research — Precision Oncology
  • Screening, Diagnosis and Imaging — Precision Oncology
  • Treatment and Clinical Outcomes — Precision Oncology
  • Supportive Care and Quality of Life — Precision Oncology
  • Case Reports and Clinical Observations — Precision Oncology
Learning Objectives
  • Interpret molecular profiling reports for treatment decisions
  • Evaluate when and how to order genomic testing
  • Design a molecular tumour board workflow
  • Identify strategies to expand precision oncology access regionally

Join leading experts in precision oncology

Submit your abstract and be part of this global scientific exchange.

Submit Abstract →All Tracks